Home
HelpTest ID CSMRT mSMART Plasma Cell Proliferative Disorder, Pre-Analysis Cell Sorting, Bone Marrow
Specimen Required
Only orderable as a reflex. For more information see MSMRT / Mayo Algorithmic Approach for Stratification of Myeloma and Risk-Adapted Therapy Report, Bone Marrow or MSMRD / Myeloma Stratification and Risk-Adapted Therapy with Reflex to Minimal Residual Disease, Bone Marrow
Specimen Type: Redirected bone marrow
Preferred: Yellow top (ACD solution A or B)
Acceptable: Lavender top (EDTA) or green top (heparin)
Specimen Volume: 4 mL
Useful For
Risk stratification of patients with multiple myeloma, which can assist in determining treatment and management decisions
Sorting plasma cells for fluorescence in situ hybridization analysis
Risk stratification of patients with newly diagnosed multiple myeloma
Method Name
Only orderable as a reflex. For more information see MSMRT / Mayo Algorithmic Approach for Stratification of Myeloma and Risk-Adapted Therapy Report, Bone Marrow or MSMRD / Myeloma Stratification and Risk-Adapted Therapy with Reflex to Minimal Residual Disease, Bone Marrow
Flow Cytometric Cell Selection
Reporting Name
MPCDS Pre-Analysis Cell Sorting, BMSpecimen Type
Bone MarrowSpecimen Minimum Volume
1 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Bone Marrow | Ambient (preferred) | 4 days | |
| Refrigerated | 4 days |
Reference Values
Only orderable as a reflex. For more information see MSMRT / Mayo Algorithmic Approach for Stratification of Myeloma and Risk-Adapted Therapy Report, Bone Marrow or MSMRD / Myeloma Stratification and Risk-Adapted Therapy with Reflex to Minimal Residual Disease, Bone Marrow
An interpretive report will be provided.
Day(s) Performed
Specimens processed Monday through Sunday
Results reported Monday through Friday
Report Available
1 to 11 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
88184-Flow Cytometry; first cell surface, cytoplasmic or nuclear marker
88185 x 5-Flow Cytometry, additional cell surface, cytoplasmic or nuclear marker (each)
LOINC Code Information
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 607682 | MPCDS Pre-Analysis Cell Sort | No LOINC Needed |
| 607688 | Final Diagnosis | No LOINC Needed |